Key facts
- Chinese AI drug discovery companies are experiencing a rise in partnerships and deals.
- U.S. authorities are increasing scrutiny of the AI drug discovery sector.
Chinese artificial intelligence drug discovery companies are experiencing a significant increase in partnerships and deals. This surge in activity occurs even as U.S. authorities intensify their scrutiny of the sector. The trend underscores the growing global reliance on AI for pharmaceutical research and development, with China emerging as a key player in this rapidly evolving field.